Trial Profile
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2024
Price :
$35
*
At a glance
- Drugs Antiandrogens (Primary) ; Antiandrogens (Primary) ; Docetaxel (Primary)
- Indications Adenocarcinoma; Bone metastases; Cancer metastases; Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SIMCAP
- 10 Jan 2024 Planned End Date changed from 30 Nov 2023 to 31 Oct 2024.
- 10 Jan 2024 Planned primary completion date changed from 30 Nov 2023 to 31 Oct 2024.
- 22 Sep 2022 Planned End Date changed from 1 Sep 2022 to 30 Nov 2023.